Balentine LLC’s Ingevity NGVT Stock Holding History

Balentine LLC’s Portfolio NGVT Stock Details NGVT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-20,754	Closed	-$1.49M	–	645
2021 Q4	$1.49M	Buy	+20,754	New	+$1.58M	0.05%	64
2020 Q1	–	Sell	-92	Closed	-$8K	–	687
2019 Q4	$8K	Hold	92	–	–	﹤0.01%	379
2019 Q3	$8K	Hold	92	–	–	﹤0.01%	408
2019 Q2	$10K	Hold	92	–	–	﹤0.01%	316
2019 Q1	$10K	Hold	92	–	–	﹤0.01%	263
2018 Q4	$8K	Hold	92	–	–	﹤0.01%	263
2018 Q3	$9K	Buy	+92	New	+$8.88K	﹤0.01%	187
2018 Q1	–	Sell	-330	Closed	-$23K	–	367
2017 Q4	$23K	Sell	330 -80	-20%	-$5.77K	﹤0.01%	365
2017 Q3	$26K	Hold	410	–	–	﹤0.01%	357
2017 Q2	$24K	Hold	410	–	–	﹤0.01%	348
2017 Q1	$25K	Hold	410	–	–	﹤0.01%	320
2016 Q4	$22K	Buy	410 +120	+41%	+$5.75K	﹤0.01%	312
2016 Q3	$13K	Buy	+290	New	+$12.2K	﹤0.01%	323

Other funds holding NGVT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

ICP

Inclusive Capital Partners San Francisco, California $26M AUM 22.24% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

Thrivent Financial for Lutherans Minneapolis, Minnesota $52.5B AUM 27.12% 1-Year Est. Return

BBCM

Broad Bay Capital Management New York $1.18B AUM 65.45% 1-Year Est. Return

MRCP

Maple Rock Capital Partners Toronto, Ontario, Canada $3.07B AUM 157.2% 1-Year Est. Return

AAM

Ardevora Asset Management London, United Kingdom $1.12B AUM 26.09% 1-Year Est. Return

Balentine LLC's NGVT Position: Q1 2022 in Review

Balentine LLC sold out of Ingevity (NGVT) in Q1 2022, closing a stake of 20,754 shares — an estimated $1.49M sold.

Balentine LLC first reported a position in NGVT in Q3 2016 and held it in 13 quarters. The position peaked at $1.49M in Q4 2021. 274 funds tracked by Wall St. Rank hold NGVT as of Q1 2022.

Balentine LLC reported no remaining Ingevity position as of Q1 2022 after selling out during the quarter.
Balentine LLC sold 20,754 Ingevity shares in Q1 2022, an estimated $1.49M.
Balentine LLC first reported a position in Ingevity in Q3 2016 and held it in 13 quarters.
Balentine LLC's Ingevity position peaked at $1.49M in Q4 2021.
274 funds tracked by Wall St. Rank held Ingevity as of Q1 2022.

Based on Balentine LLC's 13F filing for Q1 2022, filed 6 May 2022.